Show simple item record

dc.contributor.authorLangabeer, Stephen E
dc.contributor.authorCrampe, Mireille
dc.contributor.authorHaslam, Karl
dc.contributor.authorKelly, Johanna
dc.contributor.authorCahill, Mary R
dc.date.accessioned2012-01-05T12:38:28Z
dc.date.available2012-01-05T12:38:28Z
dc.date.issued2010-07
dc.identifier.citationSustained clinical remission despite suboptimal molecular response to imatinib in e1a2 BCR-ABL chronic myeloid leukemia. 2010, 34 (7):e176-7 Leuk. Res.en
dc.identifier.issn1873-5835
dc.identifier.pmid20153526
dc.identifier.doi10.1016/j.leukres.2010.01.025
dc.identifier.urihttp://hdl.handle.net/10147/200247
dc.language.isoenen
dc.subject.meshAntineoplastic Agents
dc.subject.meshDrug Resistance, Neoplasm
dc.subject.meshFemale
dc.subject.meshFusion Proteins, bcr-abl
dc.subject.meshHumans
dc.subject.meshIncidental Findings
dc.subject.meshLeukemia, Myelogenous, Chronic, BCR-ABL Positive
dc.subject.meshMiddle Aged
dc.subject.meshPiperazines
dc.subject.meshProtein Kinase Inhibitors
dc.subject.meshPyrimidines
dc.subject.meshRNA, Messenger
dc.subject.meshRNA, Neoplasm
dc.subject.meshRemission Induction
dc.subject.meshTumor Markers, Biological
dc.titleSustained clinical remission despite suboptimal molecular response to imatinib in e1a2 BCR-ABL chronic myeloid leukemia.en
dc.typeArticleen
dc.identifier.journalLeukemia researchen
dc.description.provinceMunster


Files in this item

Thumbnail
Name:
Publisher version

This item appears in the following Collection(s)

Show simple item record